Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma
Head & Neck · 2023
DOI: 10.1002/hed.27537 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Head & Neck, 2023. Verfasst von Dong Hyun Kim und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea. Hauptthemen laut MEDLINE: Carcinoma, Adenoid Cystic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: AstraZeneca, MSD, Ono Pharmaceutical.
Abstract (Originalsprache)
Background
This study analyzed the predictive value of artificial intelligence (AI)‐powered tumor‐infiltrating lymphocyte (TIL) analysis in recurrent or metastatic (R/M) adenoid cystic carcinoma (ACC) treated with axitinib.
Methods
Patients from a multicenter, prospective phase II trial evaluating axitinib efficacy in R/M ACC were included in this study. H&E whole‐side images of archival tumor tissues were analyzed by Lunit SCOPE IO, an AI‐powered spatial TIL analyzer.
Results
Twenty‐seven patients were included in the analysis. The best response was stable disease, and the median progression‐free survival (PFS) was 11.1 months (95% CI, 9.2–13.7 months). Median TIL densities in the cancer and surrounding stroma were 25.8/mm 2 (IQR, 8.3–73.0) and 180.4/mm 2 (IQR, 69.6–342.8), respectively. Patients with stromal TIL density >342.5/mm 2 exhibited longer PFS ( p = 0.012).
Conclusions
Cancer and stromal area TIL infiltration were generally low in R/M ACC. Higher stromal TIL infiltration was associated with a longer PFS with axitinib treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
- Lunit, Seoul, South Korea.
- Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, South Korea.
- Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
- Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, South Korea.
ORCID-Profile: Dong Hyun Kim, Eun Joo Kang, Bhumsuk Keam
Förderung
- AstraZeneca
- MSD
- Ono Pharmaceutical
Zitieren
APA
Kim, D. H., Lim, Y., Ock, C. Y., Park, G., Park, S., Song, H., Ma, M., Mostafavi, M., Kang, E. J., Ahn, M. J., Lee, K. W., Kwon, J. H., Yang, Y., Choi, Y. H., Kim, M. K., Ji, J. H., Yun, T., Kim, S. B., & Keam, B. (2023). Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma. Head & Neck. https://doi.org/10.1002/hed.27537
Vancouver
Kim DH, Lim Y, Ock CY, Park G, Park S, Song H, et al. Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma. Head & Neck. 2023. doi:10.1002/hed.27537
BibTeX
@article{Kim2023,
author = {Kim, Dong Hyun and Lim, Yoojoo and Ock, Chan-Young and Park, Gahee and Park, Seonwook and Song, Heon and Ma, Minuk and Mostafavi, Mohammad and Kang, Eun Joo and Ahn, Myung-Ju and Lee, Keun-Wook and Kwon, Jung Hye and Yang, Yaewon and Choi, Yoon Hee and Kim, Min Kyoung and Ji, Jun Ho and Yun, Tak and Kim, Sung-Bae and Keam, Bhumsuk},
title = {Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma},
journal = {Head & Neck},
year = {2023},
doi = {10.1002/hed.27537}
}
EUVIMED